{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:06Z","timestamp":1792425726023,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00417-019-04301-6","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T23:53:59Z","timestamp":1554335639000},"page":"1341-1351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle"],"prefix":"10.1007","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-0289","authenticated-orcid":false,"given":"Giuseppe","family":"Giannaccare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bernabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Scorcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"4301_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813\u20131826","journal-title":"N Engl J Med"},{"key":"4301_CR2","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1097\/TP.0b013e3181f5470c","volume":"90","author":"S Milosevic","year":"2010","unstructured":"Milosevic S, Bachnick B, Karim K et al (2010) Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation. Transplantation 90:1030\u20131035","journal-title":"Transplantation"},{"key":"4301_CR3","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JL Ferrara","year":"2009","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550\u20131561","journal-title":"Lancet"},{"key":"4301_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/sj.bmt.1701510","volume":"22","author":"AC Vigorito","year":"1998","unstructured":"Vigorito AC, Azevedo WM, Marques JF et al (1998) A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 22:1145\u20131151","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","volume":"355","author":"R Powles","year":"2000","unstructured":"Powles R, Mehta J, Kulkarni S et al (2000) Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 355:1231\u20131237","journal-title":"Lancet"},{"key":"4301_CR6","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1182\/blood-2010-12-323824","volume":"117","author":"M Arora","year":"2011","unstructured":"Arora M, Klein JP, Weisdorf DJ, Hassebroek A et al (2011) Chronic GVHD risk score: a center for international blood and marrow transplant research analysis. Blood 117:6714\u20136720","journal-title":"Blood"},{"key":"4301_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers ME et al (2012) Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 119:296\u2013307","journal-title":"Blood"},{"key":"4301_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204\u2013217","journal-title":"Am J Med"},{"key":"4301_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbmt.2014.12.035","volume":"21","author":"SZ Pavletic","year":"2015","unstructured":"Pavletic SZ, Vogelsang GB, Lee SJ (2015) 2014 National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: preface to the series. Biol Blood Marrow Transpl 21:387\u2013388","journal-title":"Biol Blood Marrow Transpl"},{"key":"4301_CR10","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/bmt.2012.56","volume":"47","author":"R Jacobs","year":"2012","unstructured":"Jacobs R, Tran U, Chen H et al (2012) Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 47:1470\u20131473","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/bjo.83.10.1125","volume":"83","author":"Y Ogawa","year":"1999","unstructured":"Ogawa Y, Okamoto S, Wakui M et al (1999) Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 83:1125\u20131130","journal-title":"Br J Ophthalmol"},{"key":"4301_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00003226-200310001-00004","volume":"22","author":"Y Ogawa","year":"2003","unstructured":"Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:19\u201327","journal-title":"Cornea"},{"key":"4301_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","volume":"15","author":"JAP Gomes","year":"2017","unstructured":"Gomes JAP, Azar DT, Baudouin C (2017) TFOS DEWS II iatrogenic report. Ocul Surf 15:511\u2013538","journal-title":"Ocul Surf"},{"key":"4301_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","volume":"31","author":"T Dietrich-Ntoukas","year":"2012","unstructured":"Dietrich-Ntoukas T, Cursiefen C et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in Chronic GVHD. Cornea 31:299\u2013310","journal-title":"Cornea"},{"key":"4301_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945\u2013956","journal-title":"Biol Blood Marrow Transplant"},{"key":"4301_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M et al (2015) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21:389\u2013401","journal-title":"Biol Blood Marrow Transplant"},{"key":"4301_CR17","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/srep03419","volume":"3","author":"Y Ogawa","year":"2013","unstructured":"Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI et al (2013) International chronic ocular graft-versus-host disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I). Sci Rep 3:3419","journal-title":"Sci Rep"},{"key":"4301_CR18","first-page":"111","volume":"42","author":"Y Ogawa","year":"2001","unstructured":"Ogawa Y, Yamazaki K, Kuwana M et al (2001) A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 42:111\u2013119","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR19","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1167\/iovs.02-0699","volume":"44","author":"Y Ogawa","year":"2003","unstructured":"Ogawa Y, Kuwana M, Yamazaki K et al (2003) Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 44:1888\u20131896","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/ICO.0b013e3181ea9a6b","volume":"29","author":"Y Ogawa","year":"2010","unstructured":"Ogawa Y, Shimmura S, Dogru M, Tsubota K (2010) Immune processes and pathogenic fibrosis in ocular chronic graft-versus-host disease and clinical manifestations after allogeneic hematopoietic stem cell transplantation. Cornea 29:68\u201377","journal-title":"Cornea"},{"key":"4301_CR21","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1167\/iovs.05-0227","volume":"46","author":"Y Ogawa","year":"2005","unstructured":"Ogawa Y, Kodama H, Kameyama K et al (2005) Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 46:4519\u20134527","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ajo.2015.04.002","volume":"160","author":"KS Na","year":"2015","unstructured":"Na KS, Yoo YS, Hwang KY, Mok JW, Joo CK (2015) Tear osmolarity and ocular surface parameters as diagnostic markers of ocular graft-versus-host disease. Am J Ophthalmol 160:143\u2013149","journal-title":"Am J Ophthalmol"},{"key":"4301_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41409-018-0090-z","volume":"53","author":"M Pathak","year":"2018","unstructured":"Pathak M, Diep PP, Lai X, Brinch L, Ruud E, Drolsum L (2018) Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation. Bone Marrow Transplant 53:863\u2013872","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Mitchell GL, Zadnik K (2004) The repeatability of clinical measurements of dry eye. Cornea 23:272\u2013285","journal-title":"Cornea"},{"key":"4301_CR25","first-page":"2533","volume":"17","author":"Y Ban","year":"2011","unstructured":"Ban Y, Ogawa Y, Ibrahim OM et al (2011) Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 17:2533\u20132543","journal-title":"Mol Vis"},{"key":"4301_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","volume":"115","author":"R Arita","year":"2008","unstructured":"Arita R, Itoh K, Inoue K et al (2008) Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 115:911\u2013915","journal-title":"Ophthalmology"},{"key":"4301_CR27","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/ICO.0000000000001500","volume":"37","author":"G Giannaccare","year":"2018","unstructured":"Giannaccare G, Vigo L, Pellegrini M et al (2018) Ocular surface workup with automated noninvasive measurements for the diagnosis of meibomian gland dysfunction. Cornea 37:740\u2013745","journal-title":"Cornea"},{"key":"4301_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/bmt.2015.72","volume":"50","author":"LA Engel","year":"2015","unstructured":"Engel LA, Wittig S, Bock F et al (2015) Meibography and meibomian gland measurements in ocular graft-versus-host disease. Bone Marrow Transpl 50:961\u2013967","journal-title":"Bone Marrow Transpl"},{"key":"4301_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jtos.2017.08.002","volume":"15","author":"Y Kusne","year":"2017","unstructured":"Kusne Y, Temkit M, Khera N et al (2017) Conjunctival subepithelial fibrosis and meibomian gland atrophy in ocular graft-versus-host disease. Ocul Surf 15:784\u2013788","journal-title":"Ocul Surf"},{"key":"4301_CR30","first-page":"1","volume":"0","author":"L Que","year":"2017","unstructured":"Que L, Zhang X, Li M (2017) Single-center retrospective study on meibomian gland loss in patients with ocular chronic graft-versus-host disease. Eye Contact Lens 0:1\u20137","journal-title":"Eye Contact Lens"},{"key":"4301_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/ICO.0000000000000747","volume":"35","author":"G Giannaccare","year":"2016","unstructured":"Giannaccare G, Bonifazi F, Sessa M et al (2016) Dry eye disease is already present in hematological patients before hematopoietic stem cell transplantation. Cornea 35:638\u2013643","journal-title":"Cornea"},{"key":"4301_CR32","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/eye.2017.78","volume":"31","author":"G Giannaccare","year":"2017","unstructured":"Giannaccare G, Bonifazi F, Sessa M et al (2017) Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice. Eye (Lond) 31:1417\u20131426","journal-title":"Eye (Lond)"},{"key":"4301_CR33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/ICO.0000000000001585","volume":"37","author":"G Giannaccare","year":"2018","unstructured":"Giannaccare G, Bonifazi F, Sebastiani S et al (2018) Meibomian gland dropout in hematological patients before hematopoietic stem cell transplantation. Cornea 37:1264\u20131269","journal-title":"Cornea"},{"key":"4301_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/01.ico.0000243956.22275.8c","volume":"26","author":"M Mohammadpour","year":"2007","unstructured":"Mohammadpour M (2007) Progressive corneal vascularization caused by graft-versus-host disease. Cornea 26:225\u2013226","journal-title":"Cornea"},{"key":"4301_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/eye.2001.29","volume":"15","author":"PG Tranos","year":"2001","unstructured":"Tranos PG, Forbes J, Jagger J (2001) Corneal perforation in chronic graft-versus-host disease. Eye (Lond) 15:111\u2013113","journal-title":"Eye (Lond)"},{"key":"4301_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/2008-322X.180705","volume":"11","author":"M Mohammadpour","year":"2016","unstructured":"Mohammadpour M, Maleki S, Hashemi H et al (2016) Recurrent corneal perforation due to chronic graft versus host disease; a clinicopathologic report. J Ophthalmic Vis Res 11:108\u2013111","journal-title":"J Ophthalmic Vis Res"},{"key":"4301_CR37","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1167\/iovs.15-17433","volume":"56","author":"A Kheirkhah","year":"2015","unstructured":"Kheirkhah A, Rahimi Darabad R, Cruzat A et al (2015) Corneal epithelial immune dendritic cell alterations in subtypes of dry eye disease: a pilot in vivo confocal microscopic study. Invest Ophthalmol Vis Sci 56:7179\u20137185","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR38","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1167\/iovs.16-20013","volume":"57","author":"A Kheirkhah","year":"2016","unstructured":"Kheirkhah A, Qazi Y, Arnoldner MA, Suri K, Dana R (2016) In vivo confocal microscopy in dry eye disease associated with chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 57:4686\u20134691","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR39","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s00417-017-3759-x","volume":"255","author":"TC Tepelus","year":"2017","unstructured":"Tepelus TC, Chiu GB, Maram J et al (2017) Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy. Graefes Arch Clin Exp Ophthalmol 255:2389\u20132397","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4301_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10237-w","volume":"7","author":"J He","year":"2017","unstructured":"He J, Ogawa Y, Mukai S et al (2017) In vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep 7:10720","journal-title":"Sci Rep"},{"key":"4301_CR41","doi-asserted-by":"publisher","unstructured":"Giannaccare G, Pellegrini M, Sebastiani S, Moscardelli F, Versura P, Campos EC (2019) In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system. Graefes Arch Clin Exp Ophthalmol. \n                    https:\/\/doi.org\/10.1007\/s00417-018-04225-7","DOI":"10.1007\/s00417-018-04225-7"},{"key":"4301_CR42","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/sj.bmt.1704453","volume":"33","author":"MR Robinson","year":"2004","unstructured":"Robinson MR, Lee SS, Rubin BI et al (2004) Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 33:1031\u20131035","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR43","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","volume":"116","author":"KF Tabbara","year":"2009","unstructured":"Tabbara KF, Al-Ghamdi A, Al-Mohareb F et al (2009) Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 116:1624\u20131629","journal-title":"Ophthalmology"},{"key":"4301_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000325034","volume":"54","author":"H Hosseini","year":"2010","unstructured":"Hosseini H, Kumar PV, Geramizadeh B et al (2010) Conjunctival scrape cytology findings in patients with chronic graft-versus-host disease following allogeneic bone marrow transplantation. Acta Cytol 54:272\u2013276","journal-title":"Acta Cytol"},{"key":"4301_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jtos.2016.04.003","volume":"14","author":"KR Sivaraman","year":"2016","unstructured":"Sivaraman KR, Jivrajka RV, Soin K et al (2016) Superior limbic keratoconjunctivitis-like inflammation in patients with chronic graft-versus-host disease. Ocul Surf 14:393\u2013400","journal-title":"Ocul Surf"},{"key":"4301_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1442-9071.2000.00284.x","volume":"28","author":"I Cher","year":"2000","unstructured":"Cher I (2000) Superior limbic keratoconjunctivitis: multifactorial mechanical pathogenesis. Clin Exp Ophthalmol 28:181\u2013184","journal-title":"Clin Exp Ophthalmol"},{"key":"4301_CR47","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ophtha.2004.11.035","volume":"112","author":"MA Pascuale Di","year":"2005","unstructured":"Di Pascuale MA, Espana EM, Liu DT et al (2005) Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112:904\u2013912","journal-title":"Ophthalmology"},{"key":"4301_CR48","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/ICO.0b013e31823f8d8c","volume":"31","author":"N Knop","year":"2012","unstructured":"Knop N, Korb DR, Blackie CA, Knop E (2012) The lid wiper contains goblet cells and goblet cell crypts for ocular surface lubrication during the blink. Cornea 31:668\u2013679","journal-title":"Cornea"},{"key":"4301_CR49","first-page":"351","volume":"8","author":"N Nassiri","year":"2013","unstructured":"Nassiri N, Eslani M, Panahi N, Mehravaran S, Ziaei A, Djalilian AR (2013) Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations. J Ophthalmic Vis Res 8:351\u2013358","journal-title":"J Ophthalmic Vis Res"},{"key":"4301_CR50","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","volume":"107","author":"DA Jabs","year":"1989","unstructured":"Jabs DA, Wingard J, Green WR et al (1989) The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 107:1343\u20131348","journal-title":"Arch Ophthalmol"},{"key":"4301_CR51","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/archopht.1983.01040020082014","volume":"101","author":"MK Jack","year":"1983","unstructured":"Jack MK, Jack GM, Sale GE et al (1983) Ocular manifestations of graft-v-host disease. Arch Ophthalmol 101:1080\u20131084","journal-title":"Arch Ophthalmol"},{"key":"4301_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/112067219100100106","volume":"1","author":"E Arocker-Mettinger","year":"1991","unstructured":"Arocker-Mettinger E, Skorpik F, Grabner G et al (1991) Manifestations of graft-versus-host disease following allogenic bone marrow transplantation. Eur J Ophthalmol 1:28\u201332","journal-title":"Eur J Ophthalmol"},{"key":"4301_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","volume":"58","author":"H Shikari","year":"2013","unstructured":"Shikari H, Antin JH, Dana R (2013) Ocular graft-versus-host disease: a review. Surv Ophthalmol 58:233\u2013251","journal-title":"Surv Ophthalmol"},{"key":"4301_CR54","first-page":"515","volume-title":"Hematopoietic cell transplantation","author":"KM Sullivan","year":"1999","unstructured":"Sullivan KM (1999) Graft-versus-host-disease. In: Forman SJ (ed) Hematopoietic cell transplantation. Blackwell, Oxford, pp 515\u2013536"},{"key":"4301_CR55","first-page":"426","volume-title":"Ocular infection and immunity","author":"DA Jabs","year":"1996","unstructured":"Jabs DA (1996) Ocular complications of bone marrow transplantation. In: Pepose J, Wilhelmus K (eds) Ocular infection and immunity. Mosby, St. Louis, pp 426\u2013434"},{"key":"4301_CR56","first-page":"879","volume-title":"Cornea","author":"SK Kim","year":"2004","unstructured":"Kim SK (2004) Ocular graft versus host disease. In: Krachmer JH, Mannis MJ, Holland EJ (eds) Cornea. Mosby, St Louis, pp 879\u2013885"},{"key":"4301_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jtos.2018.10.005","volume":"17","author":"G Giannaccare","year":"2019","unstructured":"Giannaccare G, Bernabei F, Pellegrini M et al (2019) Eyelid metrics assessment in patients with chronic ocular graft versus-host disease. Ocul Surf 17:98\u2013103","journal-title":"Ocul Surf"},{"key":"4301_CR58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2016.12.026","volume":"176","author":"SN Arafat","year":"2017","unstructured":"Arafat SN, Robert MC, Abud T et al (2017) Elevated neutrophil elastase in tears of ocular graft-versus-host disease patients. Am J Ophthalmol 176:46\u201352","journal-title":"Am J Ophthalmol"},{"key":"4301_CR59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jtos.2018.04.007","volume":"16","author":"S Nair","year":"2018","unstructured":"Nair S, Vanathi M, Mahapatra M et al (2018) Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients. Ocul Surf 16:352\u2013367","journal-title":"Ocul Surf"},{"key":"4301_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/01676830.2016.1193539","volume":"35","author":"K Satchi","year":"2016","unstructured":"Satchi K, McNab AA (2016) Conjunctival cicatrizing disease presenting with lacrimal obstruction. Orbit 35:321\u2013323","journal-title":"Orbit"},{"key":"4301_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/IOP.0000000000000267","volume":"32","author":"AA Campbell","year":"2016","unstructured":"Campbell AA, Jakobiec FA, Rashid A et al (2016) Bilateral sequential dacryocystitis in a patient with graft-versus-host disease. Ophthal Plast Reconstr Surg 32:89\u201392","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"4301_CR62","first-page":"125","volume":"4","author":"R Hanada","year":"1989","unstructured":"Hanada R, Ueoka Y (1989) Obstruction of nasolacrimal ducts closely related to graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 4:125\u2013126","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00002341-199303000-00005","volume":"9","author":"KV Cahill","year":"1993","unstructured":"Cahill KV, Burns JA (1993) Management of acute dacryocystitis in adults. Ophthal Plast Reconstr Surg 9:38\u201341","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"4301_CR64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.exer.2013.07.015","volume":"117","author":"von Thun Und Hohenstein-Blaul N, Funke S, Grus FH","year":"2013","unstructured":"von Thun Und Hohenstein-Blaul N, Funke S, Grus FH (2013) Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res 117:126\u2013137","journal-title":"Exp Eye Res"},{"key":"4301_CR65","first-page":"797","volume":"18","author":"A Riemens","year":"2012","unstructured":"Riemens A, Stoyanova E, Rothova A, Kuiper J (2012) Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis 18:797\u2013802","journal-title":"Mol Vis"},{"key":"4301_CR66","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.bbmt.2015.08.020","volume":"21","author":"JW Jung","year":"2015","unstructured":"Jung JW, Han SJ, Song MK et al (2015) Tear cytokines as biomarkers for chronic graft-versus-host disease. Biol Blood Marrow Transplant 21:2079\u20132085","journal-title":"Biol Blood Marrow Transplant"},{"key":"4301_CR67","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1167\/iovs.15-18615","volume":"57","author":"L Cocho","year":"2016","unstructured":"Cocho L, Fernandez I, Calonge M et al (2016) Biomarkers in ocular chronic graft versus host disease: tear cytokine- and chemokine-based predictive model. Invest Ophthalmol Vis Sci 57:746\u2013758","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR68","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1167\/iovs.18-24433","volume":"59","author":"N Gerber-Hollbach","year":"2018","unstructured":"Gerber-Hollbach N, Plattner K, O'Leary OE et al (2018) Tear film proteomics reveal important differences between patients with and without ocular GvHD after allogeneic hematopoietic cell transplantation. Invest Ophthalmol Vis Sci 59:3521\u20133530","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR69","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R et al (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15:539\u2013574","journal-title":"Ocul Surf"},{"key":"4301_CR70","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/ICO.0000000000000283","volume":"33","author":"L Berchicci","year":"2014","unstructured":"Berchicci L, Iuliano L, Miserocchi E et al (2014) Tear osmolarity in ocular graft-versus-host disease. Cornea 33:1252\u20131256","journal-title":"Cornea"},{"key":"4301_CR71","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/ICO.0000000000000494","volume":"34","author":"M Schargus","year":"2015","unstructured":"Schargus M, Meyer-ter-Vehn T, Menrath J, Grigoleit GU, Geerling G (2015) Correlation between tear film osmolarity and the disease score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in hematopoietic stem cell transplantation patients. Cornea 34:911\u2013916","journal-title":"Cornea"},{"key":"4301_CR72","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","volume":"21","author":"PA Carpenter","year":"2015","unstructured":"Carpenter PA, Kitko CL, Elad S et al (2015) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group report. Biol Blood Marrow Transplant 21:1167\u20131187","journal-title":"Biol Blood Marrow Transplant"},{"key":"4301_CR73","first-page":"1209","volume":"9","author":"X Lin","year":"2015","unstructured":"Lin X, Cavanagh HD (2015) Ocular manifestations of graft-versus-host disease: 10 years' experience. Clin Ophthalmol 9:1209\u20131213","journal-title":"Clin Ophthalmol"},{"key":"4301_CR74","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1475-1313.2009.00683.x","volume":"29","author":"MJ Doughty","year":"2009","unstructured":"Doughty MJ, Glavin S (2009) Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review. Ophthalmic Physiol Opt 29:573\u2013583","journal-title":"Ophthalmic Physiol Opt"},{"key":"4301_CR75","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s00417-005-0219-9","volume":"244","author":"W Bernauer","year":"2006","unstructured":"Bernauer W, Thiel MA, Langenauer UM et al (2006) Phosphate concentration in artificial tears. Graefes Arch Clin Exp Ophthalmol 244:1010\u20131014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4301_CR76","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/bmt.2011.205","volume":"47","author":"S Sabti","year":"2012","unstructured":"Sabti S, Halter JP, Braun Fr\u00e4nkl BC et al (2012) Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant 47:981\u2013984","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/ICO.0000000000001042","volume":"36","author":"Y Yin","year":"2017","unstructured":"Yin Y, Gong L (2017) Reversibility of gland dropout and significance of eyelid hygiene treatment in meibomian gland dysfunction. Cornea 36:332\u2013337","journal-title":"Cornea"},{"key":"4301_CR78","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","volume":"52","author":"G Geerling","year":"2011","unstructured":"Geerling G, Tauber G, Baudouin C et al (2011) The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 52:2050\u20132064","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4301_CR79","doi-asserted-by":"publisher","unstructured":"Giannaccare G, Pellegrini M, Sebastiani S et al (2019) Efficacy of omega-3 fatty acid supplementation for the treatment of dry eye disease: a meta-analysis of randomized controlled trials. Cornea. \n                    https:\/\/doi.org\/10.1097\/ICO.0000000000001884","DOI":"10.1097\/ICO.0000000000001884"},{"key":"4301_CR80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajo.2018.03.024","volume":"190","author":"J Yin","year":"2018","unstructured":"Yin J, Kheirkhah A, Dhlman T, Saboo U, Dana R (2018) Reduced efficacy of low-dose topical steroids in dry eye disease associated with graft-versus-host disease. Am J Ophthalmol 190:17\u201323","journal-title":"Am J Ophthalmol"},{"key":"4301_CR81","doi-asserted-by":"publisher","unstructured":"Inamoto Y, Petricek I, Burns L et al (2018) Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. \n                    https:\/\/doi.org\/10.1038\/s41409-018-0339-6","DOI":"10.1038\/s41409-018-0339-6"},{"key":"4301_CR82","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","volume":"25","author":"SN Rao","year":"2006","unstructured":"Rao SN, Rao RD (2006) Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Cornea 25:674\u2013678","journal-title":"Cornea"},{"key":"4301_CR83","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","volume":"25","author":"GJ Lelli Jr","year":"2006","unstructured":"Lelli GJ Jr, Musch DC, Gupta A et al (2006) Ophthalmic cyclosporine use in ocular GVHD. Cornea 25:635\u2013638","journal-title":"Cornea"},{"key":"4301_CR84","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","volume":"41","author":"Y Wang","year":"2008","unstructured":"Wang Y, Ogawa Y, Dogru M et al (2008) Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant 41:293\u2013302","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR85","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1097\/ICO.0b013e3181e456f0","volume":"29","author":"JB Malta","year":"2010","unstructured":"Malta JB, Soong HK, Shtein RM et al (2010) Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. Cornea 29:1392\u20131396","journal-title":"Cornea"},{"key":"4301_CR86","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/ICO.0000000000000436","volume":"34","author":"GE Boynton","year":"2015","unstructured":"Boynton GE, Raoof D, Niziol LM, Hussain M, Mian SI (2015) Prospective randomized trial comparing efficacy of topical loteprednol etabonate 0.5% versus cyclosporine-A 0.05% for treatment of dry eye syndrome following hematopoietic stem cell transplantation. Cornea 34:725\u2013732","journal-title":"Cornea"},{"key":"4301_CR87","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.ophtha.2016.02.044","volume":"123","author":"TB Abud","year":"2016","unstructured":"Abud TB, Amparo F, Saboo US, Di Zazzo A, Dohlman TH, Ciolino JB, Hamrah P, Dana R (2016) A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease. Ophthalmology 123:1449\u20131457","journal-title":"Ophthalmology"},{"key":"4301_CR88","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.bbmt.2007.05.006","volume":"13","author":"K Takahide","year":"2007","unstructured":"Takahide K, Parker PM, Wu M et al (2007) Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant 13:1016\u20131021","journal-title":"Biol Blood Marrow Transplant"},{"key":"4301_CR89","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/ICO.0b013e318155743d","volume":"26","author":"DS Jacobs","year":"2007","unstructured":"Jacobs DS, Rosenthal P (2007) Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 26:1195\u20131199","journal-title":"Cornea"},{"key":"4301_CR90","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/ICL.0b013e318188e205","volume":"34","author":"MM Schornack","year":"2008","unstructured":"Schornack MM, Baratz KH, Patel SV et al (2008) Jupiter scleral lenses in the management of chronic graft versus host disease. Eye Contact Lens 34:302\u2013305","journal-title":"Eye Contact Lens"},{"key":"4301_CR91","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.bbmt.2015.07.027","volume":"21","author":"C Theophanous","year":"2015","unstructured":"Theophanous C, Irvine JA, Parker P, Chiu GB (2015) Use of prosthetic replacement of the ocular surface ecosystem scleral lenses in patients with ocular chronic graft-versus-host disease. Biol Blood Marrow Transplant 21:2180\u20132184","journal-title":"Biol Blood Marrow Transplant"},{"key":"4301_CR92","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","volume":"56","author":"G Giannaccare","year":"2017","unstructured":"Giannaccare G, Versura P, Buzzi M, Primavera L, Pellegrini M, Campos EC (2017) Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfus Apher Sci 56:595\u2013604","journal-title":"Transfus Apher Sci"},{"key":"4301_CR93","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/sj.bmt.1703862","volume":"31","author":"Y Ogawa","year":"2003","unstructured":"Ogawa Y, Okamoto S, Mori T et al (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31:579\u2013583","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR94","first-page":"322","volume":"101","author":"V Tahmaz","year":"2017","unstructured":"Tahmaz V, Gehlsen U, Sauerbier L et al (2017) Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br J Ophthalmol 101:322\u2013326","journal-title":"Br J Ophthalmol"},{"key":"4301_CR95","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/aos.12801","volume":"93","author":"PA Stenwall","year":"2015","unstructured":"Stenwall PA, Bergstrom M, Seiron P et al (2015) Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction. Acta Ophthalmol 93:654\u2013657","journal-title":"Acta Ophthalmol"},{"key":"4301_CR96","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","volume":"26","author":"CC Chiang","year":"2007","unstructured":"Chiang CC, Lin JM, Chen WL, Tsai YY (2007) Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea 26:861\u2013863","journal-title":"Cornea"},{"key":"4301_CR97","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1089\/jop.2012.0002","volume":"28","author":"KS Na","year":"2012","unstructured":"Na KS, Kim MS (2012) Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. J Ocul Pharmacol Ther 28:479\u2013483","journal-title":"J Ocul Pharmacol Ther"},{"key":"4301_CR98","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.transci.2018.06.001","volume":"57","author":"M Buzzi","year":"2018","unstructured":"Buzzi M, Versura P, Grigolo B et al (2018) Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases. Transfus Apher Sci 57:549\u2013555","journal-title":"Transfus Apher Sci"},{"key":"4301_CR99","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.bmt.1705566","volume":"39","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, Jeong IY, Im SK, Park YG, Kim HJ, Choi J (2007) Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant 39:231\u2013235","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR100","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41409-018-0140-6","volume":"53","author":"Z Peric","year":"2018","unstructured":"Peric Z, Skegro I, Durakovic N et al (2018) Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease. Bone Marrow Transplant 53:1466\u20131469","journal-title":"Bone Marrow Transplant"},{"key":"4301_CR101","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.survophthal.2016.12.010","volume":"62","author":"A Zazzo Di","year":"2017","unstructured":"Di Zazzo A, Kheirkhah A, Abud TB, Goyal S, Dana R (2017) Management of high-risk corneal transplantation. Surv Ophthalmol 62:816\u2013827","journal-title":"Surv Ophthalmol"},{"key":"4301_CR102","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S0140-6736(96)11188-0","volume":"349","author":"G Pellegrini","year":"1999","unstructured":"Pellegrini G, Traverso CE, Franzi AT et al (1999) Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349:990\u2013993","journal-title":"Lancet"},{"key":"4301_CR103","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/ICO.0b013e31823f8b0c","volume":"31","author":"EJ Holland","year":"2012","unstructured":"Holland EJ, Mogilishetty G, Skeens HM et al (2012) Systemic immunosuppression in ocular surface stem cell transplantation: results of a 10-year experience. Cornea 31:655\u2013661","journal-title":"Cornea"},{"key":"4301_CR104","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/ICO.0b013e31818526a6","volume":"28","author":"D Meller","year":"2009","unstructured":"Meller D, Fuchsluger T, Pauklin M, Steuhl KP (2009) Ocular surface reconstruction in graft-versus-host disease with HLA-identical living-related allogeneic cultivated limbal epithelium after hematopoietic stem cell transplantation from the same donor. Cornea 28:233\u2013236","journal-title":"Cornea"},{"key":"4301_CR105","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1023\/A:1009924907775","volume":"19","author":"TE Starzl","year":"1998","unstructured":"Starzl TE, Demetris AJ (1998) Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth 19:441\u2013455","journal-title":"Theor Med Bioeth"},{"key":"4301_CR106","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jamaophthalmol.2017.3204","volume":"135","author":"M Busin","year":"2017","unstructured":"Busin M, Giannaccare G, Sapigni L et al (2017) Conjunctival and limbal transplantation from the same living-related bone marrow donor to patients with severe ocular graft-vs-host disease. JAMA Ophthalmol 135:1123\u20131125","journal-title":"JAMA Ophthalmol"},{"key":"4301_CR107","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/ICO.0b013e318201467c","volume":"30","author":"JM Biber","year":"2011","unstructured":"Biber JM, Skeens HM, Neff KD, Holland EJ (2011) The Cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure. Cornea 30:765\u2013771","journal-title":"Cornea"},{"key":"4301_CR108","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","volume":"54","author":"E Donnenfeld","year":"2009","unstructured":"Donnenfeld E, Pflugfelder SC (2009) Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol 54:321\u2013338","journal-title":"Surv Ophthalmol"},{"key":"4301_CR109","first-page":"201","volume":"1","author":"G Sosne","year":"2007","unstructured":"Sosne G, Ping Qiu P, Kurpakus-Wheater M (2007) Thymosin beta 4: a novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol 1:201\u2013207","journal-title":"Clin Ophthalmol"},{"key":"4301_CR110","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exer.2018.02.009","volume":"170","author":"X Han","year":"2018","unstructured":"Han X, Liu Y, Kam WR, Sullivan DA (2018) Effect of brimonidine, an \u03b12 adrenergic agonist, on human meibomian gland epithelial cells. Exp Eye Res 170:20\u201328","journal-title":"Exp Eye Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04301-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:16:43Z","timestamp":1585901803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04301-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":110,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4301"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04301-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"14 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}